Currently, there are 64.45M common shares owned by the public and among those 56.92M shares have been available to trade.
The company’s stock has a 5-day price change of -0.21% and -31.40% over the past three months. EOLS shares are trading -12.32% year to date (YTD), with the 12-month market performance down to -26.44% lower. It has a 12-month low price of $8.67 and touched a high of $17.82 over the same period. EOLS has an average intraday trading volume of 909.87K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.64%, -13.23%, and -27.50% respectively.
Institutional ownership of Evolus Inc (NASDAQ: EOLS) shares accounts for 84.45% of the company’s 64.45M shares outstanding.
It has a market capitalization of $624.12M and a beta (3y monthly) value of 1.04. The earnings-per-share (ttm) stands at -$0.89. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.24% over the week and 4.04% over the month.
Earnings per share for the fiscal year are expected to increase by 23.26%, and 393.56% over the next financial year.
Looking at the support for the EOLS, a number of firms have released research notes about the stock. BTIG Research stated their Buy rating for the stock in a research note on April 17, 2025, with the firm’s price target at $21. Barclays coverage for the Evolus Inc (EOLS) stock in a research note released on January 29, 2024 offered a Overweight rating with a price target of $16. Needham was of a view on June 23, 2022 that the stock is Buy, while Barclays gave the stock Equal Weight rating on May 12, 2022, issuing a price target of $8- $10. Truist on their part issued Buy rating on January 20, 2022.
